Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia

References

• Abaasa, A. M., Todd, J., Ekoru, K., Kalyango, J. N., Levin, J., Odeke, E., & Karamagi, C. A. (2008). Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: The experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Services Research, 8, 241.
   PubMed Web of Science ®Google Scholar
• Alemu, A., & Sebastián, M. (2010). Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Global Health Action, 29, 3.
   Google Scholar
• Bolton-Moore, C., Mubiana-Mbewe, M., Cantrell, R. A., Chintu, N, Stringer, E. M., Chi, B. H., … Stringer, J. S. (2007). Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA, 298, 1888–1899. doi:10.1001/jama.298.16.1888
   PubMed Web of Science ®Google Scholar
• Bong, C.-N., Yu, J. K., Chiang, H.-C., Huang, W.-L., Hsieh, T.-C., Schouten, E. J., … Harries, A. D. (2007). Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS, 21, 1805–1810. doi:10.1097/QAD.0b013e3282c3a9e4
   PubMed Web of Science ®Google Scholar
• Braitstein, P., B. M., Dabis, F., Schechter, M., Boulle, A., Miotti, P., Wood, R., … ART Cohort Collaboration (ART-CC) groups. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet, 367, 817–824. doi:10.1016/S0140-6736(06)68337-2
   PubMed Web of Science ®Google Scholar
• Calis, J. C., van Hensbroek, M. B., de Haan, R.J., Moons, P., Brabin, B. J., & Bates, I. (2008). HIV-associated anemia in children: A systematic review from a global perspective. AIDS, 22, 1099–1112. doi:10.1097/QAD.0b013e3282fa759f
   PubMed Web of Science ®Google Scholar
• Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. (2008). Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: A meta-analysis. AIDS, 22(1), 97–105. doi:10.1097/01.aids.0000302262.51286.a5
   PubMed Web of Science ®Google Scholar
• de Olalla, P. G., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 30(1), 105–110. doi:10.1097/00042560-200205010-00014
   PubMed Web of Science ®Google Scholar
• Ellaurie, M., Burns, E. R., & Rubinstein, A. (1990). Hematologic manifestations in pediatric HIV infection: Severe anemia as a prognostic factor. American Journal of Pediatric Hematology/Oncology, 12, 449–453. doi:10.1097/00043426-199024000-00008
   PubMedGoogle Scholar
• EPHA. (2009). Ethiopian public health Association sponsored Master’s Theses Extracts on HIV/AIDS. Extract No. 13. December, 2010. Addis Ababa, Ethiopia.
   Google Scholar
• Fenner, L., Brinkhof, M., Keiser, O., Weigel, R., Cornell, M., Moultrie, H., … International epidemiologic Databases to Evaluate AIDS in Southern Africa. (2010). Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Journal of Acquired Immune Deficiency Syndromes, 54, 524–532. doi:10.1097/QAI.0b013e3181e0c4cf
   PubMed Web of Science ®Google Scholar
• FHAPCO/MOH. (2009). ART scale-up in Ethiopia: Success and challenges. Addis Ababa: Ethiopian HIV/AIDS Prevention and Control Office (HAPCO) Plan, Monitoring and Evaluation Directorate.
   Google Scholar
• FMOH-FHAPCO. (2008). Guidelines for pediatric HIV/AIDS care and treatment in Ethiopia. Addis Ababa: Federal HIV/AIDS Prevention and Control Office, Federal Ministry of Health.
   Google Scholar
• George, E., Noël, F., Bois, G., Cassagnol, R., Estavien, L., Rouzier, … Wright, P. F. (2007). Antiretroviral therapy for HIV-1–infected children in Haiti. Journal of Infectious Diseases, 195, 1411–1418. doi:10.1086/514823
   PubMed Web of Science ®Google Scholar
• Hambisa, M. T., Ali, A., & Dessie, Y. (2013). Determinants of mortality among HIV positives after initiating antiretroviral therapy in Western Ethiopia: A hospital-based retrospective cohort study. ISRN AIDS, 491601.
   PubMedGoogle Scholar
• Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O’Shaughnessy, M. V., & Montaner, J. S. (2002). Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS, 16, 1051–1058. doi:10.1097/00002030-200205030-00012
   PubMed Web of Science ®Google Scholar
• Lepage, P., Spira, R., Kalibala, S., Pillay, K., Giaquinto, C., Castetbon, K., … International Working Group on Mother-to-Child Transmission of HIV. (1998). Care of human immunodeficiency virus-infected children in developing countries. Pediatric Infectious Disease Journal, 17, 581–586. doi:10.1097/00006454-199807000-00002
   PubMed Web of Science ®Google Scholar
• Maggiolo, F, Airoldi, M., Kleinloog, H. D., Callegaro, A., Ravasio, V., Arici, C., … Suter, F. (2007). Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clinical Trials, 8, 282–292. doi:10.1310/hct0805-282
   PubMed Web of Science ®Google Scholar
• McKinney, R. E. (1995). Growth delay, failure to thrive, and wasting in the HIV-infected child. Seminars in Pediatric Infectious Diseases, 6(1), 32–39. doi:10.1016/S1045-1870(05)80021-4
   Google Scholar
• Morfeldt-Månson, L., Böttiger, B., Nilsson, B., & von Stedingk, L. V. (1991). Clinical signs and laboratory markers in predicting progression to AIDS in HIV-1 infected patients. Scandinavian Journal of Infectious Diseases, 23, 443.
   PubMed Web of Science ®Google Scholar
• Munyagwa, M, Baisley, K., Levin, J., Brian, M., Grosskurth, H., & Maher, D. (2012). Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up. Tropical Medicine and International Health, 17, 836–843. doi:10.1111/j.1365-3156.2012.03000.x
   PubMed Web of Science ®Google Scholar
• Newell, M.-L., Coovadia, H., Cortina-Borja, M., Rollins, N., Gaillard, P., Dabis, F., & The Ghent International AIDS Society (IAS) working group on HIV infection in women and children. (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: A pooled analysis. 364, 1236–1243. doi:10.1016/S0140-6736(04)17140-7
   Google Scholar
• Obimbo, E. M., Mbori-Ngacha, D., Ochieng, J. O., Richardson, B. A., Otieno, P. A., Bosire, R., … John-Stewart, G. C. (2004). Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected African children. Pediatric Infectious Disease Journal, 23, 536–543. doi:10.1097/01.inf.0000129692.42964.30
   PubMed Web of Science ®Google Scholar
• Palella, F. J. Jr., Delaney, K., Moorman, A. C., Loveless, M. O., Fuhrer, J., & Satten, G. A., … The HIV Outpatient Study Investigators. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853–860. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Prendergast, A., Walker, A., Mulenga, V., Chintu, C., & Gibb, D. M. (2011). Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis. Clinical Infectious Diseases, 52, 953–956. doi:10.1093/cid/cir029
   PubMed Web of Science ®Google Scholar
• Reddi, A., Leeper, S., Grobler, A. C., Geddes, R., France, K. H., Dorse, G. L., … Giddy, J. (2007). Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics, 7, 13.
   PubMedGoogle Scholar
• Spira, R., Lepage, P., Msellati, P., Perre, P. V. D., Leroy, V., Simonon, A., … Dabis, F. (1999). Natural history of human immunodeficiency virus type 1 infection in children: A five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics, 104(5), e56. doi:10.1542/peds.104.5.e56
   PubMed Web of Science ®Google Scholar
• Sullivan, P. S., Hanson, D. L., Chu, S. Y., Jones, J. L., & Ward, J. W. (1998). Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood, 91, 301–308.
   PubMed Web of Science ®Google Scholar
• Sutcliffe, C. G., van Dijk J. H., Munsanje, B., Hamangaba, F., Siniwymaanzi, P., Thuma, P. E., & Moss, W. J. (2011). Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: A cohort study. PLoS One, 6, e29294. doi:10.1371/journal.pone.0029294.t004
   Google Scholar
• UNAIDS/WHO. (2008). Epidemiological fact sheets on HIV/AIDS, 2008, update. Geneva: WHOUNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance.
   Google Scholar
• van Kooten Niekerk, N. K. M., Knies, M., Howard, J., Rabie, H., Zeier, M., van Rensburg, A., … Cotton, M. F. (2006). The first 5 years of the family clinic for HIV at Tygerberg Hospital: Family demographics, survival of children and early impact of antiretroviral therapy. Journal of Tropical Pediatrics, 52(1), 3–11. doi:10.1093/tropej/fmi047
   PubMed Web of Science ®Google Scholar
• Violari, A., Cotton, M., Gibb, D., Babiker, A., Steyn, J., Madhi, S., … McIntyre, J. A. (2008). Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine, 359, 2233–2244. doi:10.1056/NEJMoa0800971
   PubMed Web of Science ®Google Scholar
• Walker, A. S., Mulenga, V., Sinyinza, F., Lishimpi, K., Nunn, A., Chintu, C., … CHAP Trial Team. (2006). Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. Journal of Acquired Immune Deficiency Syndromes, 42, 637–645. doi:10.1097/01.qai.0000226334.34717.dc
   PubMed Web of Science ®Google Scholar
• Walker, N., Schwartländer, B., & Bryce, J. (2002). Meeting international goals in child survival and HIV/AIDS. Lancet, 360, 284–289. doi:10.1016/S0140-6736(02)09550-8
   PubMed Web of Science ®Google Scholar
• Wamalwa, D. C., Obimbo, E. M., Farquhar, C., Richardson, B. A., Mbori-Ngacha, D. A., Inwani, I., … John-Stewart, G. (2010). Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: A prospective cohort. BMC Pediatrics, 10, 33.
   PubMed Web of Science ®Google Scholar
• WHO. (2012). Treatment of children living with HIV. Retrieved from http://www.who.int/hiv/topics/paediatric/en/index.html
   Google Scholar